The research shows that Kognitic's neural network model is better at predicting PCD than traditional methods.
This breakthrough has significant implications for drug development, where PCD delays can cost pharmaceutical companies between $600,000 to $8 million per day.
The platform helps these companies make informed decisions about drug development strategies and anticipate competitors' market entry timing.

Source prnewswire